Pfizer and BioNTech COVID-19 vaccine: Noting that they are not sure whether their vaccines would work against new COVID-19 variant 'Omicron, Pfizer and BioNTech promised to develop a new vaccine against the strain within 100 days.
This comes after the new COVID-19 strain, the B.1.1.529, first traced in South Africa, has been identified as a Variant of Concern by World Health Organization.
WHO named the variant with the Greek letter 'Omicron'. The variant has also been identified in Botswana, Belgium, Hong Kong and Israel. ‘Expect to develop new vaccine within 100 days’ In statement released on Friday, the companies said, "We understand the concern of experts and have immediately initiated investigations on variant B.1.1.529," BioNTech